Ajay Goel, PhD (IMAGE)

City of Hope

Ajay Goel, PhD

Caption

City of Hope researcher Ajay Goel, Ph.D., AGAF, led the development of a new, investigational blood test that could detect pancreatic cancer at its earliest stages, when the disease is more treatable and potentially curable. Called PANXEON, the liquid biopsy was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The experimental test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops.

Credit

City of Hope

Usage Restrictions

Please use credit

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.